Dysregulation of the CXCR4 signaling pathway can contribute to cancer growth, invasion, metastasis, and angiogenesis, underscoring its significance in cancer progression, hematopoietic stem cell transplantation, and immune-related diseases. Here, CXCR4 is linked to cancer.